Orkuveita Reykjavíkur
Orkuveita Reykjavíkur has extended market making agreements with Arion Bank hf., Íslandsbanki hf., Kvika banki hf. and Landsbankinn hf. regarding OR‘s bond series; OR020934 GB and OR180255 GB on the secondary market. The bonds have already been admitted to trading on Nasdaq Iceland, but the market makers' obligations under the agreement took effect on 27 January 2021.
The purpose of this is to strengthen trading in the bonds covered by the agreement, increase their liquidity in the secondary market and promote normal price formation.
Market makers undertake to submit bids and offers for the bonds on the Exchange every day before the market opens. Bids must always be at least 20 m. kr. in each category at nominal value and tenders shall be renewed no later than within 15 minutes of receipt.
The maximum difference between market makers‘ bid and ask spread is determined by the price of valid bids and may not exceed 1.0% on OR 020934 GB. The maximum difference between bid and ask spread on OR 180255 may not exceed 1.5%.
If a market maker trades for a total of 120 m. kr. or more nominal value in any given trading day and in one or more classes of bonds in automatic matching, he may deviate from the maximum difference between bid and ask bids for the remainder of the trading day.
Over the contractual period of this agreement, market makers may receive temporary bond loans in the category of bonds covered by the agreement.
Market making with the category OR090546 will not be renewed.
Further information:
Ingvar Stefánsson, Chief Financial Officer of OR, tel. 516-6100, e-mail ingvar.stefansson@or.is
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Novo Nordisk A/S18.9.2025 10:45:34 CEST | Press release
Novo Nordisk A/S: Ozempic® reduces the risk of heart attack, stroke and death by 23% compared to dulaglutide in the first head-to-head real-world study
Glice AG18.9.2025 10:41:41 CEST | Press release
Europe's Leading Research Institute Confirms Breakthrough: Swiss Company Glice Develops Synthetic Ice with Real-Ice Glide
Sparinvest SICAV18.9.2025 10:40:53 CEST | Pressemeddelelse
Sparinvest SICAV suspenderer handel med afdeling
Sompo International Holdings Ltd.18.9.2025 10:30:00 CEST | Press release
Sompo appoints Alessandrea Quane as CEO, International Markets
Kitron ASA18.9.2025 10:01:45 CEST | Press release
Kitron ASA - New share capital registered
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom